← Browse by Condition
Medical Condition

hgbl

Total Trials
1
Recruiting Now
1
Trial Phases
EARLY_Phase 1
NCT04512716 EARLY_Phase 1
Recruiting

Iomab-ACT: A Pilot Study of 131-I Apamistamab Followed by CD19-Targeted CAR T-Cell Therapy for Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia or Diffuse Large B-Cell Lymphoma

Enrollment
12 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance...
View Trial →